Stock Analiz

Nautilus Biotechnology, Inc. (NAUT) stock forecast and price target

Price $2.32 · data as of November 13, 2026

12-month price target

Average target$4.00
Upside / downside+72.4%
Analysts3
ConsensusNone

Analyst ratings

Strong buy 0Buy 4Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.48—$668500
Next fiscal year
ends December 31, 2027
$-0.48—$6M
Next quarter
ends December 31, 2026
$-0.13—$262500
Quarter after
ends March 31, 2027
$-0.12—$387500

Consensus of the analysts covering Nautilus Biotechnology, updated daily. In the last 30 days 3 estimates were raised and 0 lowered.

Frequently asked questions

What is the Nautilus Biotechnology stock price target?

The average 12-month target from 3 analysts is $4.00, 72.4% above the current price of $2.32 Targets range from $4.00 to $4.00.

Is Nautilus Biotechnology a buy according to analysts?

The consensus rating is “None” (4 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Nautilus Biotechnology expected to earn?

Analysts expect EPS of $-0.48 for the fiscal year ending December 31, 2026 and $-0.48 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.